JPWO2006013750A1 - 脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物の飼育方法 - Google Patents
脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物の飼育方法 Download PDFInfo
- Publication number
- JPWO2006013750A1 JPWO2006013750A1 JP2006531398A JP2006531398A JPWO2006013750A1 JP WO2006013750 A1 JPWO2006013750 A1 JP WO2006013750A1 JP 2006531398 A JP2006531398 A JP 2006531398A JP 2006531398 A JP2006531398 A JP 2006531398A JP WO2006013750 A1 JPWO2006013750 A1 JP WO2006013750A1
- Authority
- JP
- Japan
- Prior art keywords
- bran
- residue
- defatted
- weight
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 36
- 239000000463 material Substances 0.000 title claims abstract description 18
- 235000013305 food Nutrition 0.000 title claims abstract description 14
- 235000013402 health food Nutrition 0.000 title claims abstract description 14
- 230000037356 lipid metabolism Effects 0.000 title claims abstract description 13
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims description 9
- 238000003975 animal breeding Methods 0.000 title claims description 3
- 235000002378 plant sterols Nutrition 0.000 claims abstract description 20
- 150000002632 lipids Chemical class 0.000 claims abstract description 18
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical class OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 claims abstract description 18
- 150000002148 esters Chemical class 0.000 claims abstract description 17
- 102000011690 Adiponectin Human genes 0.000 claims description 19
- 108010076365 Adiponectin Proteins 0.000 claims description 19
- 239000008280 blood Substances 0.000 claims description 16
- 210000004369 blood Anatomy 0.000 claims description 16
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 13
- 206010022489 Insulin Resistance Diseases 0.000 claims description 11
- 239000008157 edible vegetable oil Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 239000003925 fat Substances 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 5
- 235000014593 oils and fats Nutrition 0.000 claims description 4
- 208000008589 Obesity Diseases 0.000 abstract description 12
- 235000020824 obesity Nutrition 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 244000144972 livestock Species 0.000 abstract description 5
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 241000209094 Oryza Species 0.000 description 13
- 235000007164 Oryza sativa Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 235000009566 rice Nutrition 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 210000001789 adipocyte Anatomy 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 230000003579 anti-obesity Effects 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000001785 ferulic acid Nutrition 0.000 description 3
- 229940114124 ferulic acid Drugs 0.000 description 3
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- YPMOAQISONSSNL-UHFFFAOYSA-N 8-hydroxyoctyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCO YPMOAQISONSSNL-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
- 229960001641 troglitazone Drugs 0.000 description 1
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Polymers & Plastics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Alternative & Traditional Medicine (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
Abstract
脂質代謝調節作用を有するを有するヒドロキシ桂皮酸類縁体植物性ステロールエステル類等の画分を含む脱脂糠又は残滓糠を健康食品又は動物用飼料の素材として用いた。健康食品又は動物用飼料中の脂質が1〜20重量%の場合、含有させる脱脂糠又は残滓糠は1〜15重量%の範囲が好ましい。
Description
Claims (18)
- 脱脂糠又は残滓糠からなることを特徴とする脂質代謝調節作用を有する食品素材。
- 前記脱脂糠又は残滓糠が、血中アディポネクチン濃度上昇作用を有する画分を含むことを特徴とする請求項1に記載の食品素材。
- 前記脱脂糠又は残滓糠が、インスリン耐性を低下させる作用を有する画分を含むことを特徴とする請求項1に記載の食品素材。
- 前記画分がヒドロキシ桂皮酸類縁体植物性ステロールエステル類であることを特徴とする請求項2又は3に記載の食品素材。
- 脱脂糠又は残滓糠を原料素材の一つとしていることを特徴とする脂質代謝調節作用を有する健康食品。
- 前記脱脂糠又は残滓糠が、血中アディポネクチン濃度上昇作用を有する画分を含むことを特徴とする請求項5に記載の健康食品。
- 前記脱脂糠又は残滓糠が、インスリン耐性を低下させる作用を有する画分を含むことを特徴とする請求項5に記載の健康食品。
- 前記画分がヒドロキシ桂皮酸類縁体植物性ステロールエステル類であることを特徴とする請求項6又は7に記載の健康食品。
- 脂質を1〜20重量%含有し、且つ脱脂糠又は残滓糠を1〜15重量%含有してなることを特徴とする脂質代謝調節作用を有する動物用飼料。
- 前記脂質として食用油脂類を3〜10重量%含有し、且つ前記脱脂糠又は残滓糠を5〜10重量%含有していることを特徴とする請求項9に記載の動物用飼料。
- 前記脱脂糠又は残滓糠が、血中アディポネクチン濃度上昇作用を有する画分を含むことを特徴とする請求項9又は10に記載の動物用飼料。
- 前記脱脂糠又は残滓糠が、インスリン耐性を低下させる作用を有する画分を含むことを特徴とする請求項9又は10に記載の動物用飼料。
- 前記画分がヒドロキシ桂皮酸類縁体植物性ステロールエステル類であることを特徴とする請求項11又は12に記載の動物用飼料。
- 脂質を1〜20重量%含有し、且つ脱脂糠又は残滓糠を1〜15重量%含有してなる動物用飼料を与えて動物を飼育することを特徴とする動物の飼育方法。
- 前記脂質として食用油脂類を3〜10重量%含有し、且つ前記脱脂糠又は残滓糠を5〜10重量%含有していることを特徴とする請求項14に記載の動物の飼育方法。
- 前記脱脂糠又は残滓糠が、血中アディポネクチン濃度上昇作用を有する画分を含むことを特徴とする請求項14又は15に記載の動物の飼育方法。
- 前記脱脂糠又は残滓糠が、インスリン耐性を低下させる作用を有する画分を含むことを特徴とする請求項14又は15に記載の動物の飼育方法。
- 前記画分がヒドロキシ桂皮酸類縁体植物性ステロールエステル類であることを特徴とする請求項16又は17に記載の動物の飼育方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006531398A JP4785140B2 (ja) | 2004-08-04 | 2005-07-26 | 脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物の飼育方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004227822 | 2004-08-04 | ||
JP2004227822 | 2004-08-04 | ||
JP2006531398A JP4785140B2 (ja) | 2004-08-04 | 2005-07-26 | 脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物の飼育方法 |
PCT/JP2005/013630 WO2006013750A1 (ja) | 2004-08-04 | 2005-07-26 | 脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物の飼育方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2006013750A1 true JPWO2006013750A1 (ja) | 2008-07-31 |
JP4785140B2 JP4785140B2 (ja) | 2011-10-05 |
Family
ID=35787040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006531398A Active JP4785140B2 (ja) | 2004-08-04 | 2005-07-26 | 脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物の飼育方法 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4785140B2 (ja) |
WO (1) | WO2006013750A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016513966A (ja) * | 2013-03-15 | 2016-05-19 | ニューサート サイエンシーズ, インコーポレイテッド | サーチュイン活性化剤によるペットの処置 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008099448A1 (ja) * | 2007-02-09 | 2008-08-21 | Masayoshi Yamaguchi | 糖尿病性疾患の予防・治療剤 |
JP5499415B2 (ja) * | 2009-09-18 | 2014-05-21 | 国立大学法人東京海洋大学 | アディポネクチン分泌調節剤 |
CN103889411B (zh) | 2011-07-15 | 2018-03-16 | 纽斯尔特科学公司 | 用于调节代谢途径的组合物和方法 |
MX2015006023A (es) | 2012-11-13 | 2016-03-31 | Nusirt Sciences Inc | Composiciones y metodos para incrementar el metabolismo energetico. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0825891B2 (ja) * | 1993-06-25 | 1996-03-13 | 株式会社薬理学中央研究所 | 脱脂米胚芽由来のリパーゼインヒビター |
JP2001097880A (ja) * | 1999-09-28 | 2001-04-10 | Otsuka Pharmaceut Factory Inc | 脱脂糠由来のリパーゼ阻害物質 |
JP4865955B2 (ja) * | 2001-04-18 | 2012-02-01 | 株式会社リアル | α−グルコシダーゼ阻害剤及び食品又は飼料の製造方法並びに添加剤の製造方法 |
JP2004091462A (ja) * | 2002-09-02 | 2004-03-25 | Oriza Yuka Kk | 糖質吸収阻害剤 |
JP4846990B2 (ja) * | 2003-08-06 | 2011-12-28 | 株式会社テラ・ブレインズ | アディポネクチン分泌促進剤 |
-
2005
- 2005-07-26 JP JP2006531398A patent/JP4785140B2/ja active Active
- 2005-07-26 WO PCT/JP2005/013630 patent/WO2006013750A1/ja active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016513966A (ja) * | 2013-03-15 | 2016-05-19 | ニューサート サイエンシーズ, インコーポレイテッド | サーチュイン活性化剤によるペットの処置 |
Also Published As
Publication number | Publication date |
---|---|
JP4785140B2 (ja) | 2011-10-05 |
WO2006013750A1 (ja) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lai et al. | Nutritional studies of rice bran oil | |
US20100086638A1 (en) | Feed formulations containing docosahexaenoic acid | |
Kolodziejczyk et al. | The application of flax and hemp seeds in food, animal feed and cosmetics production | |
TWI331902B (ja) | ||
Huang et al. | The effect of adlay oil on plasma lipids, insulin and leptin in rat | |
DE69832520T2 (de) | Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes | |
JP4785140B2 (ja) | 脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物の飼育方法 | |
Callaway et al. | Hempseed oil | |
Dharavath et al. | Camelina sativa (L.) Crantz A mercantile crop with speckled pharmacological activities | |
Sulistyowati et al. | Quality of milk fatty acid during late lactation in dairy goat fed on PUFA-diet supplemented with yeast and | |
WO2013039210A1 (ja) | Gip上昇抑制剤 | |
JP2009291187A (ja) | 食生活改善用食品組成物 | |
JP2006306813A (ja) | 肥満細胞増殖抑制剤 | |
JPWO2011122389A1 (ja) | 糖尿病の予防又は治療用油脂組成物 | |
AU2020260090C9 (en) | Novel hemp and PEA formulation and its use | |
JP2010105923A (ja) | アカシア属樹皮由来物を含有するPPARδ発現促進剤 | |
Ju | Can flaxseed lower cholesterol levels? | |
Ristić-Medić et al. | Soybeans, Flaxseeds, and Fish Oil in the Treatment of Renal Disease | |
JP2019052122A (ja) | アディポネクチン分泌促進剤、脂肪前駆細胞分化促進剤並びにそれらを含む医薬組成物、食品及び飼料 | |
JP2013063937A (ja) | Gip上昇抑制剤 | |
Potgieter | Effect of ꞷ-3 lipid sources on layer performance and egg quality during peak production | |
JP4179842B2 (ja) | ペットフード | |
Al-Juburi et al. | Efficacy of senna leaves extract and rosuvastatin on blood parameters of inducing hyperlipidemia laboratory rats. | |
EP1424073A1 (en) | Anti diarrhoea compositions | |
JP2022150493A (ja) | 血中中鎖脂肪酸濃度の上昇方法、血中中鎖脂肪酸濃度上昇剤、医薬組成物、食品組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080714 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080714 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110329 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110523 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110614 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110708 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4785140 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140722 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |